Oprelvekin Product Approval Information - Licensing Action

Proper name: Oprelvekin
Tradename: Neumega
Manufacturer: Genetics Institute, Inc, St. Davids, PA, License #1163
Revised Package Insert: To state that a safe and effective dose has not been established for pediatric patients and to add important new safety information
Approval Date: 9/18/2002
Type of submission: Biologics license application supplement


Approval Letter - (PDF)

Label (PDF)

Page Last Updated: 02/16/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.